Clinical trial

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

NCT00508222

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-06-01

PhasePHASE3

Study timeline

Study start (unknown)2007-06-01Date precision: month

Registry last updated2012-05-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Kaletra TabletsDRUG

Sponsors & collaborators

Ottawa Hospital Research Institutelead sponsor

Abbottcollaborator

Mapped research locations

VancouverBritish Columbia, Canada1 OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00508222 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.